comparemela.com

StockNews.com assumed coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a research note issued to investors on Tuesday morning. The firm issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Performance Shares of NASDAQ:DFFN opened at $3.51 on Tuesday. Diffusion Pharmaceuticals has a 1 year low of $3.42 and a 1 […]

Related Keywords

,News Ratings For Diffusion Pharmaceuticals Daily ,Diffusion Pharmaceuticals Inc ,Jpmorgan Chase Co ,Diffusion Pharmaceuticals Stock Performance ,Diffusion Pharmaceuticals ,Hedge Funds Weigh In On Diffusion Pharmaceuticals ,Exchange Commission ,Nasdaq ,Get Rating ,Trans Sodium Crocetinate ,Diffusion Pharmaceuticals Daily ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.